{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:56:18Z","timestamp":1789646178940,"version":"4.0.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10384-016-0469-6","type":"journal-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T05:26:41Z","timestamp":1470634001000},"page":"486-491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm"],"prefix":"10.1007","volume":"60","author":[{"given":"Yoshihiko","family":"Isshiki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,8]]},"reference":[{"key":"469_CR1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00002341-199809000-00002","volume":"14","author":"RL Anderson","year":"1998","unstructured":"Anderson RL, Patel BC, Holds JB, Jordan DR. Blepharospasm: past, present, and future. Ophthalmic Plast Reconstr Surg. 1998;14:305\u201317.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"469_CR2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003495-200464030-00002","volume":"64","author":"G Defazio","year":"2004","unstructured":"Defazio G, Livrea P. Primary blepharospasm: diagnosis and management. Drugs. 2004;64:237\u201344.","journal-title":"Drugs"},{"key":"469_CR3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/jnnp.39.12.1204","volume":"39","author":"CD Marsden","year":"1976","unstructured":"Marsden CD. Blepharospasm\u2013oromandibular dystonia syndrome (Brueghel\u2019s syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry. 1976;39:1204\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"469_CR4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0002-9394(03)00895-X","volume":"136","author":"JB Kerrison","year":"2003","unstructured":"Kerrison JB, Lancaster JL, Zamarripa FE, Richardson LA, Morrison JC, Holck DE, et al. Positron emission tomography scanning in essential blepharospasm. Am J Ophthalmol. 2003;136:846\u201352.","journal-title":"Am J Ophthalmol"},{"key":"469_CR5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00415-006-0468-5","volume":"254","author":"Y Suzuki","year":"2007","unstructured":"Suzuki Y, Mizoguchi S, Kiyosawa M, Mochizuki M, Ishiwata K, Wakakura M, et al. Glucose hypermetabolism in the thalamus of patients with essential blepharospasm. J Neurol. 2007;254:890\u20136.","journal-title":"J Neurol"},{"key":"469_CR6","doi-asserted-by":"publisher","unstructured":"Emoto H, Suzuki Y, Wakakura M, Horie C, Kiyosawa M, Mochizuki M, et al. Photophobia in essential blepharospasm\u2014a positron emission tomographic study. Mov Disord Off J Mov Disord Soc. 2010;25:433\u20139. doi: 10.1002\/mds.22916 .","DOI":"10.1002\/mds.22916"},{"key":"469_CR7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/jnnp.2005.087148","volume":"77","author":"T Etgen","year":"2006","unstructured":"Etgen T, Muhlau M, Gaser C, Sander D. Bilateral grey-matter increase in the putamen in primary blepharospasm. J Neurol Neurosurg Psychiatry. 2006;77:1017\u201320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"469_CR8","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1001\/jama.1982.03330230060037","volume":"248","author":"J Jankovic","year":"1982","unstructured":"Jankovic J, Havins WE, Wilkins RB. Blinking and blepharospasm. Mechanism, diagnosis, and management. JAMA. 1982;248:3160\u20134.","journal-title":"JAMA"},{"key":"469_CR9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/mds.21495","volume":"22","author":"M Obermann","year":"2007","unstructured":"Obermann M, Yaldizli O, De Greiff A, Lachenmayer ML, Buhl AR, Tumczak F, et al. Morphometric changes of sensorimotor structures in focal dystonia. Mov Disord. 2007;22:1117\u201323.","journal-title":"Mov Disord"},{"issue":"Pt 4","key":"469_CR10","first-page":"435","volume":"2","author":"JS Elston","year":"1988","unstructured":"Elston JS, Marsden CD, Grandas F, Quinn NP. The significance of ophthalmological symptoms in idiopathic blepharospasm. Eye. 1988;2(Pt 4):435\u20139.","journal-title":"Eye"},{"key":"469_CR11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","volume":"51","author":"F Grandas","year":"1988","unstructured":"Grandas F, Elston J, Quinn N, Marsden CD. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry. 1988;51:767\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"469_CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/bjo.81.6.439","volume":"81","author":"K Tsubota","year":"1997","unstructured":"Tsubota K, Fujihara T, Kaido M, Mori A, Mimura M, Kato M. Dry eye and Meige\u2019s syndrome. Br J Ophthal. 1997;81:439\u201342.","journal-title":"Br J Ophthal"},{"key":"469_CR13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9394(14)77954-1","volume":"99","author":"N Shorr","year":"1985","unstructured":"Shorr N, Seiff SR, Kopelman J. The use of botulinum toxin in blepharospasm. Am J Ophthalmol. 1985;99:542\u20136.","journal-title":"Am J Ophthalmol"},{"key":"469_CR14","unstructured":"Price J, O\u2019Day J. A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin. J Clin Neuroophthalmol. 1993;13:67\u201371."},{"key":"469_CR15","first-page":"1842","volume":"24","author":"H Spiera","year":"1997","unstructured":"Spiera H, Asbell PA, Simpson DM. Botulinum toxin increases tearing in patients with Sjogren\u2019s syndrome: a preliminary report. J Rheumatol. 1997;24:1842\u20133.","journal-title":"J Rheumatol"},{"key":"469_CR16","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1111\/aos.12002","volume":"91","author":"DI Park","year":"2013","unstructured":"Park DI, Shin HM, Lee SY, Lew H. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm. Acta Ophthalmol. 2013;91:e108\u201312. doi: 10.1111\/aos.12002 .","journal-title":"Acta Ophthalmol"},{"issue":"591\u20137","key":"469_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajo.2013.11.014","volume":"157","author":"R Lu","year":"2014","unstructured":"Lu R, Huang R, Li K, Zhang X, Yang H, Quan Y, Li Q. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation. Am J Ophthalmol. 2014;157(591\u20137):e1\u20132. doi: 10.1016\/j.ajo.2013.11.014 .","journal-title":"Am J Ophthalmol"},{"key":"469_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28:863\u201373. doi: 10.1002\/mds.25475 .","journal-title":"Mov Disord"},{"key":"469_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12325-012-0033-9","volume":"29","author":"M Nakamura","year":"2012","unstructured":"Nakamura M, Imanaka T, Sakamoto A. Diquafosol ophthalmic solution for dry eye treatment. Adv Ther. 2012;29:579\u201389. doi: 10.1007\/s12325-012-0033-9 .","journal-title":"Adv Ther"},{"key":"469_CR20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.2003.019869","volume":"75","author":"M Wakakura","year":"2004","unstructured":"Wakakura M, Tsubouchi T, Inouye J. Etizolam and benzodiazepine induced blepharospasm. J Neurol Neurosurg Psychiatry. 2004;75:506\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"469_CR21","doi-asserted-by":"publisher","unstructured":"Sakane Y, Yamaguchi M, Yokoi N, Uchino M, Dogru M, Oishi T, et al. Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire. JAMA Ophthalmol. 2013;131:1331\u20138. doi: 10.1001\/jamaophthalmol.2013.4503 .","DOI":"10.1001\/jamaophthalmol.2013.4503"},{"key":"469_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/ICO.0b013e31815be9c8","volume":"27","author":"S Koh","year":"2008","unstructured":"Koh S, Maeda N, Hori Y, Inoue T, Watanabe H, Hirohara Y, et al. Effects of suppression of blinking on quality of vision in borderline cases of evaporative dry eye. Cornea. 2008;27:275\u20138. doi: 10.1097\/ICO.0b013e31815be9c8 .","journal-title":"Cornea"},{"key":"469_CR23","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1167\/iovs.06-0018","volume":"47","author":"S Koh","year":"2006","unstructured":"Koh S, Maeda N, Hirohara Y, Mihashi T, Ninomiya S, Bessho K, Watanabe H, Fujikado T, Tano Y. Serial measurements of higher-order aberrations after blinking in normal subjects. Invest Ophthalmol Vis Sci. 2006;47:3318\u201324.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"469_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1167\/iovs.07-0762","volume":"49","author":"S Koh","year":"2008","unstructured":"Koh S, Maeda N, Hirohara Y, Mihashi T, Bessho K, Hori Y, Inoue T, Watanabe H, Fujikado T, Tano Y. Serial measurements of higher-order aberrations after blinking in patients with dry eye. Invest Ophthalmol Vis Sci. 2008;49:133\u20138. doi: 10.1167\/iovs.07-0762 .","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"469_CR25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jcrs.2006.01.021","volume":"32","author":"S Koh","year":"2006","unstructured":"Koh S, Maeda N, Ninomiya S, Watanabe H, Fujikado T, Tano Y, et al. Paradoxical increase of visual impairment with punctal occlusion in a patient with mild dry eye. J Cataract Refract Surg. 2006;32:689\u201391.","journal-title":"J Cataract Refract Surg"},{"key":"469_CR26","doi-asserted-by":"publisher","first-page":"209e","DOI":"10.1097\/PRS.0b013e31825500ba","volume":"130","author":"AC Victoria","year":"2012","unstructured":"Victoria AC, Pino A. Botulinum toxin type a and its uses in dry eye disease. Plast Reconstr Surg. 2012;130:209e\u201310e. doi: 10.1097\/PRS.0b013e31825500ba .","journal-title":"Plast Reconstr Surg"},{"key":"469_CR27","doi-asserted-by":"crossref","unstructured":"Yokoi N, Georgiev GA. Tear-film-oriented diagnosis and therapy for dry eye. In: Yokoi N, editor. Dry eye syndrome: basic and clinical perspectives. London: Future Medicine Ltd.; 2013. p. 96\u2013108.","DOI":"10.2217\/ebo.12.340"},{"key":"469_CR28","doi-asserted-by":"crossref","unstructured":"Yabiku MM, Sartori Jde F, Sarraff EP, Osaki TH, Hossaka SK, Pereira CI, et al. Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin. Arq Bras Oftalmol. 2011;74:414\u20136 (in Portuguese).","DOI":"10.1590\/S0004-27492011000600006"},{"key":"469_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1097\/ICO.0b013e318294f97e","volume":"32","author":"S Koh","year":"2013","unstructured":"Koh S, Inoue Y, Sugmimoto T, Maeda N, Nishida K. Effect of rebamipide ophthalmic suspension on optical quality in the short break-up time type of dry eye. Cornea. 2013;32:1219\u201323. doi: 10.1097\/ICO.0b013e318294f97e .","journal-title":"Cornea"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-016-0469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-016-0469-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-016-0469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:10:42Z","timestamp":1498320642000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-016-0469-6"}},"subtitle":["BTX improves dry eye in patients with BEB"],"short-title":[],"issued":{"date-parts":[[2016,8,8]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1007\/s10384-016-0469-6","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,8]]}}}